Decentralized testing for tuberculosis with on-site Xpert Ultra: the XPEL TB trial

Dates

01/15/2016 - 12/31/2020

PI

David Dowdy, MD, PhD, ScM

This is a highly pragmatic cluster randomized trial to compare the impact, implementation, and cost-effectiveness of on-site versus “hub-and-spoke” testing for TB using Xpert Ultra in 20 primary health centers in Uganda.

Projects

mHealth for improved TB contact investigation...

This multicenter randomized study is evaluating the implementation, effectiveness, cost-effectiveness, and population-level...

Read More

A Blueprint for Success: Understanding the...

We are using a combination of statistical analysis and transmission modeling, in collaboration with the NYC Dept of Health &...

Read More

Understanding the role of repeat testing and...

We have developed a Markov model of serial IGRA testing to help improve testing algorithms with TST vs. IGRA in low-risk...

Read More

Immunotherapy Targeting MTB Persisters in the...

The goal of this research program is to determine whether enhanced immunity to critical components of the Mtb stringent response...

Read More